KRP vs TMO · P/E 33, rev $309.3M vs P/E 24, rev $44.56B
Kimbell Royalty Partners LP (KRP) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Kimbell Royalty Partners LP (KRP) is a oil & gas e&p company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported KRP revenue for 2024-12-31 was $309.3M. Net income was $11.1M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. KRP currently screens at market cap $1.64B and trailing P/E 33.1.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
KRP currently screens at market cap $1.64B and trailing P/E 33.1. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the KRP and TMO stock pages for the full models.
Not investment advice.